Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 8;54(3):97-99.

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Affiliations

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Ahmed Naguy et al. Psychopharmacol Bull. .

Abstract

NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.

Keywords: SIBs; SUDs; binge eating; naltrexone; obesity; paraphilia; pathologic gambling.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Naguy A, Badr BHM. Buprobion-Myth-Busting. CNS Spetr . 2021;27(5):545–546. - PubMed
    1. Naguy A. Viewpoint: Borderline Personality Disorder-Light At the End of the Tunnel. Isr J Psychiatry Relat Sci . 2020;57(1):41–43.
    1. Moghaddas A, Dianatkhah M, Ghaffari S et al. The Potential Role of Naltrexone in Borderline Personality Disorder. Iran J Psychiatry . 2017;12(2):142–146. - PMC - PubMed
    1. Elchaar GM, Maisch NM, Augusto LMG et al. Efficacy and Safety of Naltrexone Use in Pediatric Patients with Autistic Disorder. Ann Pharmacother . 2006;40(6):1086–1095. - PubMed
    1. Bartley CA, Bloch MH. Meta-Analysis: Pharmacological Treatment of Pathological Gambling. Expert Rev Neurother . 2013;13:887–894. - PubMed

LinkOut - more resources